Threshold Ventures and Monograph Capital, two investors, led a $25m Series B round in ODAIA, a developer of MAPTUAL, an AI-powered commercial insights SaaS platform, with participation from Flint Capital, BDC Capital, StandUp Ventures and Graphite Ventures. “ODAIA’s ability to constantly ingest and update a broad mix of life sciences data and turn it into comprehensive insights in near-real-time turns pharmaceutical sales from reactive to proactive. We’re thrilled to lead their Series B financing. ODAIA helps get life changing drugs into the hands of those who need them faster and more efficiently," Emily Melton, Threshold Ventures Managing Partner.